# FENTANYL CITRATE
> **NDA215870** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2023-02-08
## Drug
- **FDA Application Number:** NDA215870
- **Application type:** New Drug Application
- **Brand name:** FENTANYL CITRATE
- **Generic name:** Fentanyl Citrate
- **Active ingredients:** FENTANYL CITRATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** EXELA PHARMA
- **First approval:** 2023-02-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215870)
---
*AI Analytics · CC0 1.0*